Cormorant Asset Management’s Precision BioSciences DTIL Stock Holding History

Cormorant Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-11,551	Closed	-$1.07M	–	82
2022 Q1	$1.07M	Hold	11,551	–	–	0.08%	73
2021 Q4	$2.56M	Hold	11,551	–	–	0.15%	67
2021 Q3	$4M	Hold	11,551	–	–	0.16%	76
2021 Q2	$4.34M	Hold	11,551	–	–	0.15%	87
2021 Q1	$3.59M	Hold	11,551	–	–	0.08%	101
2020 Q4	$2.89M	Hold	11,551	–	–	0.07%	95
2020 Q3	$2.13M	Hold	11,551	–	–	0.08%	87
2020 Q2	$2.89M	Hold	11,551	–	–	0.11%	75
2020 Q1	$2.09M	Sell	11,551 -4,033	-26%	-$1.06M	0.1%	69
2019 Q4	$6.49M	Hold	15,584	–	–	0.26%	54
2019 Q3	$3.92M	Hold	15,584	–	–	0.24%	59
2019 Q2	$6.2M	Sell	15,584 -10,417	-40%	-$4.19M	0.36%	58
2019 Q1	$14M	Buy	+26,001	New	+$13.8M	0.95%	35

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cormorant Asset Management's DTIL Position: Q2 2022 in Review

Cormorant Asset Management sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 11,551 shares — an estimated $1.07M sold.

Cormorant Asset Management first reported a position in DTIL in Q1 2019 and held it in 13 quarters. The position peaked at $14M in Q1 2019. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Cormorant Asset Management reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
Cormorant Asset Management sold 11,551 Precision BioSciences shares in Q2 2022, an estimated $1.07M.
Cormorant Asset Management first reported a position in Precision BioSciences in Q1 2019 and held it in 13 quarters.
Cormorant Asset Management's Precision BioSciences position peaked at $14M in Q1 2019.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Cormorant Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.